AARP Magazine: “Osteoporosis: know your risks, test your bones”
28/11/2022 -
Press releases
Medimaps Group appoints Meinhard F. Schmidt as Board Chairman; adds Anne Le Grand and five additional board members
14/11/2022 -
Press releases
Medimaps Group announces partnership with OsteoSys to bring trabecular bone score to Korea’s leading bone densitometry platform
04/03/2022 -
Press releases
Medical reimbursement now available for trabecular bone score (TBS), an advanced medtech solution with artificial intelligence capabilities, for osteoporosis fracture risk assessment
01/01/2021 -
Press releases
Medimaps Group raises $20 million to expand and to commercialize AI product portfolio for bone health assessment utilizing routine medical images
Medimaps Group is certified to ISO 13485:2016 (certificate C831121). TBS Insight is FDA 510(k) cleared and MDR compliant, CE-marked under notified body 2460.
Please note that you are now accessing content reserved for healthcare professionals only. By accepting, you confirm that you are a healthcare professional.
Click “OK” to confirm you are a Healthcare Professional.